Posted inMarket An2 Therapeutics Director Robin Readnour Sells Over $97,000 in Company Shares Discover the recent insider transaction involving An2 Therapeutics Director Robin Readnour, who sold nearly 97322 dollars in company stock. Posted by Prasenjit Bhowmik November 17, 2026